Discovering the Immunologic Mechanism of Ascaris-induced Allergic Airway Disease.
Project Number5K08AI143968-05
Contact PI/Project LeaderWEATHERHEAD, JILL ELIZABETH
Awardee OrganizationBAYLOR COLLEGE OF MEDICINE
Description
Abstract Text
Summary: Dr. Weatherhead is an Assistant Professor of Pediatric Tropical Medicine and Infectious Diseases
at Baylor College of Medicine (BCM) and a physician-scientist in the area of immunoparasitology. Her career
goal is to be an expert in parasitic health disparities and perform high-quality basic science research that
improves the health of children living in poverty. Children living in poverty are at high risk of parasitic infections
such as ascariasis, which infects over 800 million children and is associated with significant morbidity including
allergic airway disease. Dr. Weatherhead aims to dissect the complex host immune response to ascariasis in
order to highlight novel interventions that are urgently needed to prevent morbidity in children living in poverty.
Her unique skill set will allow her to serve as a link between laboratory discovery and field implementation of
newly developed anthelminthic targets. To accomplish these goals, Dr. Weatherhead has developed a
comprehensive career development plan which combines thorough mentoring and training activities integrated
into her basic and translational research program. She will have scheduled meetings with her invested
mentorship team, Dr. David Corry, an authority in molecular immunology and allergic airway disease, and Dr.
Peter Hotez, a global leader in parasitology and vaccine development. Dr. Weatherhead will receive additional
expert-level mentorship on the microbial-host immune interface from her scientific advisory committee.
Mentored research will be supplemented with formal training activities including graduate-level coursework,
participation in national scientific meetings and instruction in scientific communication and academic
leadership. Her career development plan is supported by a world-class scientific environment which offers
ample opportunities for junior faculty development and provides all the resources needed to achieve her career
goals. Dr. Weatherhead's research will evaluate the innate and adaptive immunologic mechanism by which
Ascaris larval lung migration induces allergic airway disease. The first aim will define the molecular pathway
involved in innate immune activation during pulmonary ascariasis. The second aim will determine when and for
how long the host loses peripheral immune tolerance as a result of Ascaris-induced adaptive immune
activation. Both aims will evaluate the immune pathways in the presence and absence of protease activity.
Questions outlined in this proposal are highly significant to the field of tropical medicine and parasitology
having the potential to shift our understanding of the complex parasite-host relationship, lending support to the
hypothesis that ascariasis is a leading cause of allergic airway disease in endemic regions. This proposal will
advance the comprehension of the mechanistic pathways of Ascaris-induced allergic airway disease as well as
provide therapeutic insight into asthma in general, suggesting novel interventional targets that are critically
needed to prevent morbidity in children. The mentored career development activities proposed in this
application will allow Dr. Weatherhead to evolve as an independent investigator in immunoparasitology.
Public Health Relevance Statement
Project Narrative
Ascariasis (roundworm) is the most common intestinal parasitic infection globally and causes severe life-long
illness in children. The larval stage ascariasis can cause an asthma-like allergic airway disease. This proposal
will identify the immunologic mechanisms of Ascaris-induced allergic airway disease in order to develop
interventions that are urgently needed to prevent significant illness in children globally.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AccelerationAccountingAdaptive Immune SystemAdvisory CommitteesAllergensAntigensAreaAscariasisAscarisAsthmaAttenuatedBasic ScienceCell PhysiologyCellsChildChild HealthChildhoodCommunicable DiseasesCommunicationComplexComprehensionDataDevelopmentDevelopment PlansDissectionEnvironmentExtrinsic asthmaFibrinogenGoalsHelper-Inducer T-LymphocyteHospitalizationHost-Parasite RelationsIgEImmuneImmune ToleranceImmune responseImmunologicsInfectionInflammatoryIngestionInnate Immune ResponseInnate Immune SystemInstructionInterleukin-13Interleukin-4Interleukin-5InterventionIntestinesInvestmentsK-Series Research Career ProgramsLaboratoriesLarvaLeadershipLigandsLinkLungMediatingMedicineMentorsMentorshipMolecularMolecular ImmunologyMorbidity - disease rateMusNematodaParasitic infectionParasitologyPathogenesisPathway interactionsPeptide HydrolasesPeripheralPersonsPhenotypePhysiciansPovertyRegulatory T-LymphocyteResearchResearch PersonnelResearch ProposalsResolutionResourcesRoleSTAT6 Transcription FactorScheduleScientistSignal TransductionSymptomsTLR4 geneTeacher Professional DevelopmentTh2 CellsTherapeuticTraining ActivityTranslational ResearchTropical MedicineUnited States National Institutes of HealthVaccinesadaptive immune responseairway hyperresponsivenessallergic airway diseaseasthma modelauthoritycareercareer developmentcollegecytokineeggfungushealth disparityhelminth infectionhigh riskimmune activationimprovedinnovationinsightmeetingsmicrobialmicrobial hostmigrationmouse modelnew therapeutic targetnovelpathogenpreventprofessorresponseskillstranslational research programvaccine development
National Institute of Allergy and Infectious Diseases
CFDA Code
855
DUNS Number
051113330
UEI
FXKMA43NTV21
Project Start Date
20-February-2020
Project End Date
31-January-2025
Budget Start Date
01-February-2024
Budget End Date
31-January-2025
Project Funding Information for 2024
Total Funding
$160,784
Direct Costs
$148,874
Indirect Costs
$11,910
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Allergy and Infectious Diseases
$160,784
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5K08AI143968-05
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5K08AI143968-05
Patents
No Patents information available for 5K08AI143968-05
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5K08AI143968-05
Clinical Studies
No Clinical Studies information available for 5K08AI143968-05
News and More
Related News Releases
No news release information available for 5K08AI143968-05
History
No Historical information available for 5K08AI143968-05
Similar Projects
No Similar Projects information available for 5K08AI143968-05